Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM3 | P20309 | 9/20 | 0.54 |
| ▸ | CHRM2 | P08172 | 3/20 | 0.54 |
| ▸ | CHRM1 | P11229 | 3/20 | 0.54 |
| ▸ | HRH1 | P35367 | 3/20 | 0.54 |
| ▸ | MAPT | P10636 | 3/20 | 0.54 |
| ▸ | CHRM5 | P08912 | 2/20 | 0.54 |
| ▸ | HTR2A | P28223 | 2/20 | 0.54 |
| ▸ | LMNA | P02545 | 2/20 | 0.54 |
| ▸ | ESR1 | P03372 | 1/20 | 0.54 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.54 |
| ▸ | KCNE1 | P15382 | 1/20 | 0.54 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.54 |
| ▸ | HRH2 | P25021 | 1/20 | 0.54 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.54 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.54 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.54 |
| ▸ | KCNQ1 | P51787 | 1/20 | 0.54 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.54 |
| ▸ | CACNA1C | Q13936 | 1/20 | 0.54 |
| ▸ | SCN5A | Q14524 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1496992 | 0.88 | CHRM3 (0.56) | CHRM3CHRM2CHRM1HRH1MAPT | |
| SCHEMBL19212507 | 0.82 | CHRM3 (0.51) | CHRM3CHRM2CHRM1HRH1MAPT | |
| SCHEMBL724557 | 0.80 | CHRM3 (0.63) | CHRM3CHRM2CHRM1HRH1MAPT | |
| SCHEMBL724558 | 0.80 | CHRM3 (0.63) | CHRM3CHRM2CHRM1HRH1MAPT | |
| SCHEMBL14988049 | 0.79 | CHRM3 (0.58) | CHRM3CHRM2CHRM1HRH1MAPT | |
| SCHEMBL6757073 | 0.74 | CHRM3 (0.55) | CHRM3CHRM2CHRM1HRH1MAPT | |
| SCHEMBL1809355 | 0.74 | CHRM3 (0.55) | CHRM3CHRM2CHRM1HRH1MAPT | |
| SCHEMBL1809358 | 0.74 | CHRM3 (0.55) | CHRM3CHRM2CHRM1HRH1MAPT | |
| SCHEMBL5614313 | 0.74 | CHRM3 (0.65) | CHRM3CHRM2CHRM1HRH1MAPT | |
| SCHEMBL3770623 | 0.73 | CHRM3 (0.54) | CHRM3CHRM2CHRM1HRH1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9315450-B2 | Desfesoterodine salts | RATIOPHARM GMBH (DE) | 2016-04-19 | — | — | US | disclosed |
| EP-2800735-B1 | PROCESS FOR THE PREPARATION OF FESOTERODINE | ALEMBIC PHARMACEUTICALS LTD (IN) | 2016-03-30 | — | — | EP | disclosed |
| EP-2760822-B1 | DESFESOTERODINE SALTS | RATIOPHARM GMBH (DE) | 2016-03-23 | — | — | EP | disclosed |
| US-9085509-B2 | Process for preparing fesoterodine | ALEMBIC PHARMACEUTICALS LIMITED (IN) | 2015-07-21 | — | — | US | disclosed |
| US-20150152044-A1 | DESFESOTERODINE SALTS | RATIOPHARM GMBH (DE) | 2015-06-04 | — | — | US | disclosed |
| EP-2686288-B1 | A PROCESS FOR PREPARING FESOTERODINE | ALEMBIC PHARMACEUTICALS LTD (IN) | 2015-03-25 | — | — | EP | disclosed |
| US-20140378699-A1 | PROCESS FOR THE PREPARATION OF FESOTERODINE | ALEMBIC PHARMACEUTICALS LIMITED (IN) | 2014-12-25 | — | — | US | disclosed |
| EP-2800735-A2 | PROCESS FOR THE PREPARATION OF FESOTERODINE | Alembic Pharmaceuticals Limited (IN) | 2014-11-12 | — | — | EP | disclosed |
| EP-2760822-A1 | DESFESOTERODINE SALTS | Ratiopharm GmbH (DE) | 2014-08-06 | — | — | EP | disclosed |
| US-20140039216-A1 | PROCESS FOR PREPARING FESOTERODINE | ALEMBIC PHARMACEUTICALS LIMITED (IN) | 2014-02-06 | — | — | US | disclosed |
| EP-2686288-A1 | A PROCESS FOR PREPARING FESOTERODINE | Alembic Pharmaceuticals Limited (IN) | 2014-01-22 | — | — | EP | disclosed |
| EP-2686288-A1 | A PROCESS FOR PREPARING FESOTERODINE | Alembic Pharmaceuticals Limited (IN) | 2014-01-22 | — | — | EP | disclosed |
| WO-2013188829-A1 | DESFESOTERODINE SALTS | RATIOPHARM GMBH (DE) | 2013-12-19 | — | — | WO | disclosed |
| WO-2013035084-A2 | PROCESS FOR THE PREPARATION OF FESOTERODINE | ALEMBIC PHARMACEUTICALS LIMITED (IN) | 2013-03-14 | — | — | WO | disclosed |
| WO-2012137047-A1 | A PROCESS FOR PREPARING FESOTERODINE | ALEMBIC PHARMACEUTICALS LIMITED (IN) | 2012-10-11 | — | — | WO | disclosed |
| WO-2012137047-A1 | A PROCESS FOR PREPARING FESOTERODINE | ALEMBIC PHARMACEUTICALS LIMITED (IN) | 2012-10-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140378699-A1 | PROCESS FOR THE PREPARATION OF FESOTERODINE | MAOB, NISCH, TES | CHRM3 66/4885CHRM2 265/4885CHRM1 668/4885 |
| US-20140039216-A1 | PROCESS FOR PREPARING FESOTERODINE | FES, QDPR, CYP4F3 | CHRM3 220/4885CHRM2 417/4885CHRM1 940/4885 |
| US-20150152044-A1 | DESFESOTERODINE SALTS | TES, SYMPK, ADRB3 | CHRM3 88/4885CHRM2 223/4885CHRM1 433/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.